RecallRadar

FDA Device recall Z-1504-2023

Atellica IM Cortisol 50T (Material Number 10995538), 250T (Material Number 10995537), and REF 250T (Material Number 11206248)

On 2023-05-10 the FDA classified a Class II recall of Atellica IM Cortisol 50T (Material Number 10995538), 250T (Material Number 10995537), and REF 250T (Material Number 11206248) by Siemens Healthcare Diagnostics, citing there is a negative bias with urine patient samples and urine cortisol Quality Control (QC) results intermittently out of range low.

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1504-2023
ClassificationClass II
Statusongoing
Initiated2023-03-16
Published2023-05-10
Last updated2026-09-13 11:56 UTC
CompanySiemens Healthcare Diagnostics
DistributionUS

Product

Atellica IM Cortisol 50T (Material Number 10995538), 250T (Material Number 10995537), and REF 250T (Material Number 11206248). In vitro diagnostic use in the quantitative determination of cortisol in human serum, plasma (EDTA and lithium heparin), and urine.

Reason

There is a negative bias with urine patient samples and urine cortisol Quality Control (QC) results intermittently out of range low.

Identifiers

code_info
Atellica IM Cortisol (50T) UDI-DI: 00630414598659; Kit Lot Numbers: 50732343 50733343 88975345 29106347 29107347 and hi…Atellica IM Cortisol (50T) UDI-DI: 00630414598659; Kit Lot Numbers: 50732343 50733343 88975345 29106347 29107347 and higher; Atellica IM Cortisol 250T UDI-DI: 00630414598642; Kit Lot Numbers: 50734343 88974345 29105347 and higher; Atellica IM Cortisol (REF) 250T UDI-DI: 00630414293608; Kit Lot Numbers: 53842343 58039343 94430345 and higher

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1504-2023%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.